Literature DB >> 10828019

Conserved amino acids in metal-binding motifs of PDE3A are involved in substrate and inhibitor binding.

W Zhang1, R W Colman.   

Abstract

The activity of phosphodiesterase (PDE)3A requires divalent cations. Putative metal-binding sites are expected at 2 highly conserved metal-binding motifs, HXXXH(X)(25)E. A functional truncated recombinant PDE3A containing the catalytic domain (PDE3Atriangle up1) and mutant proteins were expressed in a baculovirus/Sf9 cell system. All the mutant proteins had decreased catalytic efficiency (k(cat)/K(m)). Mutants H752A, H756A, and E825A had k(cat) of less than 0.0008 s(-1) to 0.0475 s(-1) compared to PDE3Atriangle up1, with 1.86 second(-1), with unchanged K(m). Although E866A had a k(cat) of 0.235 s(-1), the K(m) for cyclic adenosine monophosphate (cAMP) was increased 11-fold and the K(i) for cyclic guanosine monophosphate (cGMP) was 27-fold higher than PDE3Atriangle up1. The K(i) of H836A for cGMP was 177-fold higher than that of PDE3Atriangle up1. The K(m) for E971A was 5-fold higher than PDE3Atriangle up1. These results suggest that the cAMP and cGMP binding sites are overlapping, but not identical, involving both common and different amino acids. Mutants E825A, H836A, and E866A showed low activity in a metal ion-free assay; however, their enzymatic activities were increased 4- to 10-fold in buffers containing Mn(2+), Mg(2+), or Co(2+). This observation indicates that conserved amino acids in the second metal-binding motif might not be involved in binding divalent cations but may serve other functions such as substrate or inhibitor binding in PDE3A.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10828019

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  Cyclic GMP signaling is involved in the luteinizing hormone-dependent meiotic maturation of mouse oocytes.

Authors:  Sergio Vaccari; James L Weeks; Minnie Hsieh; Frank S Menniti; Marco Conti
Journal:  Biol Reprod       Date:  2009-05-27       Impact factor: 4.285

2.  Identification of overlapping but distinct cAMP and cGMP interaction sites with cyclic nucleotide phosphodiesterase 3A by site-directed mutagenesis and molecular modeling based on crystalline PDE4B.

Authors:  W Zhang; H Ke; A P Tretiakova; B Jameson; R W Colman
Journal:  Protein Sci       Date:  2001-08       Impact factor: 6.725

Review 3.  Hormonal control of mammalian oocyte meiosis at diplotene stage.

Authors:  Meijia Zhang; Guoliang Xia
Journal:  Cell Mol Life Sci       Date:  2011-11-02       Impact factor: 9.261

4.  A novel mutation and phenotypes in phosphodiesterase 6 deficiency.

Authors:  Stephen H Tsang; Irena Tsui; Chai Lin Chou; Jana Zernant; Eneli Haamer; Reza Iranmanesh; Joaquin Tosi; Rando Allikmets
Journal:  Am J Ophthalmol       Date:  2008-08-23       Impact factor: 5.258

5.  A new nonhydrolyzable reactive cGMP analogue, (Rp)-guanosine-3',5'-cyclic-S-(4-bromo-2,3-dioxobutyl)monophosphorothioate, which targets the cGMP binding site of human platelet PDE3A.

Authors:  Su H Hung; Andy H Liu; Robin A Pixley; Penelope Francis; LaTeeka D Williams; Christopher M Matsko; Karine D Barnes; Sharmila Sivendran; Roberta F Colman; Robert W Colman
Journal:  Bioorg Chem       Date:  2008-04-03       Impact factor: 5.275

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.